Infection
From immunology to artificial intelligence: revolutionizing latent tuberculosis infection diagnosis with machine learning
Nov
World Health Organization. Global tuberculosis report 2022. Geneva: World Health Organization; 2022. https://www.who.int/teams/global-tuberculosis-programme/tb-reports
Bagcchi S. WHO’s global tuberculosis report 2022. Lancet Microbe. 2023;4(1):e20.
Google Scholar
Ernst JD. The immunological life cycle of tuberculosis. Nat Rev Immunol. 2012;12(8):581–91.
Google Scholar
Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis. 2017;64(2):e1-33.
Google Scholar
Cohen A, Mathiasen VD, Schon T, Wejse C. The global prevalence of latent tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2019;54(3):1900655.
Google Scholar
Khabibullina NF, Kutuzova DM, Burmistrova IA, Lyadova IV. The biological and clinical aspects of a latent tuberculosis infection. Trop Med Infect Dis. 2022;7(3):48.
Google Scholar
Houben RMGJ, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med. 2016;13(10):e1002152.
Google Scholar
Jilani TN, Avula A, Zafar Gondal A, Siddiqui AH. Active tuberculosis. In: StatPearls. Treasure Island (FL): StatPearls Publishing LLC; 2023.
Ding C, Hu M, Guo W, Hu W, Li X, Wang S, et al. Prevalence trends of latent tuberculosis infection at the global, regional, and country levels from 1990–2019. Int J Infect Dis. 2022;122:46.
Google Scholar
Kiazyk S, Ball TB. Latent tuberculosis infection: an overview. Can Commun Dis Rep. 2017;43(3–4):62–6.
Google Scholar
Luo Y, Xue Y, Song H, Tang G, Liu W, Bai H, et al. Machine learning based on routine laboratory indicators promoting the discrimination between active tuberculosis and latent tuberculosis infection. J Infect. 2022;84(5):648–57.
Google Scholar
Estévez O, Anibarro L, Garet E, Pallares Á, Barcia L, Calviño L, et al. An RNA-seq based machine learning approach identifies latent tuberculosis patients with an active tuberculosis profile. Front Immunol. 2020;11:1470.
Google Scholar
Gong W, Wu X. Differential diagnosis of latent tuberculosis infection and active tuberculosis: a key to a successful tuberculosis control strategy. Front Microbiol. 2021;12(3126):745592.
Google Scholar
Chee CBE, Reves R, Zhang Y, Belknap R. Latent tuberculosis infection: opportunities and challenges. Respirology. 2018;23(10):893–900.
Google Scholar
Hauck FR, Neese BH, Panchal AS, El-Amin W. Identification and management of latent tuberculosis infection. Am Fam Physician. 2009;79(10):879–86.
Google Scholar
Gutti G, Arya K, Singh SK. Latent tuberculosis infection (LTBI) and its potential targets: an investigation into dormant phase pathogens. Mini Rev Med Chem. 2019;19(19):1627–42.
Google Scholar
Yang Z, Rosenthal M, Rosenberg NA, Talarico S, Zhang L, Marrs C, et al. How dormant is Mycobacterium tuberculosis during latency? A study integrating genomics and molecular epidemiology. Infect Genet Evol. 2011;11(5):1164–7.
Google Scholar
Gordon SV, Eiglmeier K, Garnier T, Brosch R, Parkhill J, Barrell B, et al. Genomics of Mycobacterium bovis. Tuberculosis. 2001;81(1–2):157–63.
Google Scholar
Chen J, Su X, Zhang Y, Wang S, Shao L, Wu J, et al. Novel recombinant RD2- and RD11-encoded Mycobacterium tuberculosis antigens are potential candidates for diagnosis of tuberculosis infections in BCG-vaccinated individuals. Microbes Infect. 2009;11(10–11):876–85.
Google Scholar
Meier NR, Jacobsen M, Ottenhoff THM, Ritz N. A systematic review on novel Mycobacterium tuberculosis antigens and their discriminatory potential for the diagnosis of latent and active tuberculosis. Front Immunol. 2018;9:2476.
Google Scholar
Ji P, Fan X, Wu K, Lu S. Research progress on the antigens associated with latent infection of Mycobacterium tuberculosis. Zhonghua Wei Sheng Wu Xue He Mian Yi Xue Za Zhi. 2015;35(1):59–64 (in Chinese).
Google Scholar
Zellweger JP, Sotgiu G, Corradi M, Durando P. The diagnosis of latent tuberculosis infection (LTBI): currently available tests, future developments, and perspectives to eliminate tuberculosis (TB). Med Lav. 2020;111(3):170–83.
Google Scholar
Crouser ED, White P, Caceres EG, Julian MW, Papp AC, Locke LW, et al. A novel in vitro human granuloma model of sarcoidosis and latent tuberculosis infection. Am J Respir Cell Mol Biol. 2017;57(4):487–98.
Google Scholar
Rosser A, Stover C, Pareek M, Mukamolova GV. Resuscitation-promoting factors are important determinants of the pathophysiology in Mycobacterium tuberculosis infection. Crit Rev Microbiol. 2017;43(5):621–30.
Google Scholar
Downing KJ, Mischenko VV, Shleeva MO, Young DI, Young M, Kaprelyants AS, et al. Mutants of Mycobacterium tuberculosis lacking three of the five rpf-like genes are defective for growth in vivo and for resuscitation in vitro. Infect Immun. 2005;73(5):3038–43.
Google Scholar
Arroyo L, Marín D, Franken KLMC, Ottenhoff THM, Barrera LF. Potential of DosR and Rpf antigens from Mycobacterium tuberculosis to discriminate between latent and active tuberculosis in a tuberculosis endemic population of Medellin Colombia. BMC Infect Dis. 2018;18(1):26.
Google Scholar
Zhu W, Plikaytis BB, Shinnick TM. Resuscitation factors from mycobacteria: homologs of Micrococcus luteus proteins. Tuberculosis. 2003;83(4):261–9.
Google Scholar
Cohen-Gonsaud M, Barthe P, Bagnéris C, Henderson B, Ward J, Roumestand C, et al. The structure of a resuscitation-promoting factor domain from Mycobacterium tuberculosis shows homology to lysozymes. Nat Struct Mol Biol. 2005;12(3):270–3.
Google Scholar
Segueni N, Benmerzoug S, Rose S, Gauthier A, Bourigault ML, Reverchon F, et al. Innate myeloid cell TNFR1 mediates first line defence against primary Mycobacterium tuberculosis infection. Sci Rep. 2016;6:22454.
Google Scholar
Koeken V, Verrall AJ, Netea MG, Hill PC, van Crevel R. Trained innate immunity and resistance to Mycobacterium tuberculosis infection. Clin Microbiol Infect. 2019;25(12):1468–72.
Google Scholar
Cadena AM, Flynn JL, Fortune SM. The importance of first impressions: early events in Mycobacterium tuberculosis infection influence Outcome. MBio. 2016;7(2):e00342-e416.
Google Scholar
McClean CM, Tobin DM. Macrophage form, function, and phenotype in mycobacterial infection: lessons from tuberculosis and other diseases. Pathog Dis. 2016;74(7):ftw068.
Google Scholar
Hmama Z, Peña-Díaz S, Joseph S, Av-Gay Y. Immunoevasion and immunosuppression of the macrophage by Mycobacterium tuberculosis. Immunol Rev. 2015;264(1):220–32.
Google Scholar
Middleton AM, Chadwick MV, Nicholson AG, Dewar A, Groger RK, Brown EJ, et al. Interaction of Mycobacterium tuberculosis with human respiratory mucosa. Tuberculosis. 2002;82(2–3):69–78.
Google Scholar
Peyron P, Vaubourgeix J, Poquet Y, Levillain F, Botanch C, Bardou F, et al. Foamy macrophages from tuberculous patients’ granulomas constitute a nutrient-rich reservoir for M tuberculosis persistence. PLoS Pathog. 2008;4(11):e1000204.
Google Scholar
Mattila JT, Ojo OO, Kepka-Lenhart D, Marino S, Kim JH, Eum SY, et al. Microenvironments in tuberculous granulomas are delineated by distinct populations of macrophage subsets and expression of nitric oxide synthase and arginase isoforms. J Immunol. 2013;191(2):773–84.
Google Scholar
El Kasmi KC, Qualls JE, Pesce JT, Smith AM, Thompson RW, Henao-Tamayo M, et al. Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat Immunol. 2008;9(12):1399–406.
Google Scholar
Duque-Correa MA, Kuhl AA, Rodriguez PC, Zedler U, Schommer-Leitner S, Rao M, et al. Macrophage arginase-1 controls bacterial growth and pathology in hypoxic tuberculosis granulomas. Proc Natl Acad Sci U S A. 2014;111(38):E4024–32.
Google Scholar
Khan A, Hunter RL, Jagannath C. Emerging role of mesenchymal stem cells during tuberculosis: the fifth element in cell mediated immunity. Tuberculosis. 2016;101S:S45-52.
Google Scholar
Keane J, Balcewicz-Sablinska MK, Remold HG, Chupp GL, Meek BB, Fenton MJ, et al. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect Immun. 1997;65(1):298–304.
Google Scholar
Harding JS, Schreiber HA, Sandor M. Granuloma transplantation: an approach to study Mycobacterium-host interactions. Front Microbiol. 2011;2:245.
Google Scholar
Gaffney E, Murphy D, Walsh A, Connolly S, Basdeo SA, Keane J, et al. Defining the role of neutrophils in the lung during infection: implications for tuberculosis disease. Front Immunol. 2022;13:984293.
Google Scholar
Yang CT, Cambier CJ, Davis JM, Hall CJ, Crosier PS, Ramakrishnan L. Neutrophils exert protection in the early tuberculous granuloma by oxidative killing of mycobacteria phagocytosed from infected macrophages. Cell Host Microbe. 2012;12(3):301–12.
Google Scholar
Mantegazza AR, Savina A, Vermeulen M, Perez L, Geffner J, Hermine O, et al. NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells. Blood. 2008;112(12):4712–22.
Google Scholar
Barnes PF, Leedom JM, Chan LS, Wong SF, Shah J, Vachon LA, et al. Predictors of short-term prognosis in patients with pulmonary tuberculosis. J Infect Dis. 1988;158(2):366–71.
Google Scholar
Dallenga T, Schaible UE. Neutrophils in tuberculosis–first line of defence or booster of disease and targets for host-directed therapy?. Pathog Dis. 2016;74(3):ftw012.
Google Scholar
Eruslanov EB, Lyadova IV, Kondratieva TK, Majorov KB, Scheglov IV, Orlova MO, et al. Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice. Infect Immun. 2005;73(3):1744–53.
Google Scholar
Divangahi M, Chen M, Gan H, Desjardins D, Hickman TT, Lee DM, et al. Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nat Immunol. 2009;10(8):899–906.
Google Scholar
Ahmad S, Amoudy HA, Thole JE, Young DB, Mustafa AS. Identification of a novel protein antigen encoded by a Mycobacterium tuberculosis-specific RD1 region gene. Scand J Immunol. 1999;49(5):515–22.
Google Scholar
Albayrak N, Dirix V, Aerts L, Van Praet A, Godefroid A, Dauby N, et al. Differential expression of maturation and activation markers on NK cells in patients with active and latent tuberculosis. J Leukoc Biol. 2022;111(5):1031–42.
Google Scholar
Mah AY, Cooper MA. Metabolic regulation of natural killer cell IFN-gamma production. Crit Rev Immunol. 2016;36(2):131–47.
Google Scholar
Perera Molligoda Arachchige PM. Human NK cells: from development to effector functions. Innate Immun. 2021;27(3):212–29.
Google Scholar
Morandi B, Bougras G, Muller WA, Ferlazzo G, Munz C. NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN-gamma secretion. Eur J Immunol. 2006;36(9):2394–400.
Google Scholar
Zhou Y, Lan H, Shi H, Wu P, Zhou Y. Evaluating the diversity of circulating natural killer cells between active tuberculosis and latent tuberculosis infection. Tuberculosis. 2022;135:102221.
Google Scholar
Geltink RIK, Kyle RL, Pearce EL. Unraveling the complex interplay between T cell metabolism and function. Annu Rev Immunol. 2018;36:461–88.
Google Scholar
Sia JK, Bizzell E, Madan-Lala R, Rengarajan J. Engaging the CD40-CD40L pathway augments T-helper cell responses and improves control of Mycobacterium tuberculosis infection. PLoS Pathog. 2017;13(8):e1006530.
Google Scholar
Infante-Duarte C, Kamradt T. Th1/Th2 balance in infection. Springer Semin Immunopathol. 1999;21(3):317–38.
Google Scholar
Awasthi A, Kuchroo VK. Th17 cells: from precursors to players in inflammation and infection. Int Immunol. 2009;21(5):489–98.
Google Scholar
Ogongo P, Tezera LB, Ardain A, Nhamoyebonde S, Ramsuran D, Singh A, et al. Tissue-resident-like CD4+ T cells secreting IL-17 control Mycobacterium tuberculosis in the human lung. J Clin Invest. 2021;131(10):e142014.
Google Scholar
Gopal R, Monin L, Slight S, Uche U, Blanchard E, Fallert Junecko BA, et al. Unexpected role for IL-17 in protective immunity against hypervirulent Mycobacterium tuberculosis HN878 infection. PLoS Pathog. 2014;10(5):e1004099.
Google Scholar
Lin PL, Flynn JL. CD8 T cells and Mycobacterium tuberculosis infection. Semin Immunopathol. 2015;37(3):239–49.
Google Scholar
van Pinxteren LA, Cassidy JP, Smedegaard BH, Agger EM, Andersen P. Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells. Eur J Immunol. 2000;30(12):3689–98.
Google Scholar
Chavez-Galan L, Illescas-Eugenio J, Alvarez-Sekely M, Baez-Saldana R, Chavez R, Lascurain R. Tuberculosis patients display a high proportion of CD8+ T cells with a high cytotoxic potential. Microbiol Immunol. 2019;63(8):316–27.
Google Scholar
Lewinsohn DM, Grotzke JE, Heinzel AS, Zhu L, Ovendale PJ, Johnson M, et al. Secreted proteins from Mycobacterium tuberculosis gain access to the cytosolic MHC class-I antigen-processing pathway. J Immunol. 2006;177(1):437–42.
Google Scholar
Sanchez C, Jaramillo-Valverde L, Capristano S, Solis G, Soto A, Valdivia-Silva J, et al. Antigen-induced IL-1RA production discriminates active and latent tuberculosis infection. Microorganisms. 2023;11(6):1385.
Google Scholar
Ji DX, Yamashiro LH, Chen KJ, Mukaida N, Kramnik I, Darwin KH, et al. Type I interferon-driven susceptibility to Mycobacterium tuberculosis is mediated by IL-1Ra. Nat Microbiol. 2019;4(12):2128–35.
Google Scholar
Jiang F, Peng C, Cheng P, Wang J, Lian J, Gong W. PP19128R, a multiepitope vaccine designed to prevent latent tuberculosis infection, induced immune responses in silico and in vitro assays. Vaccines. 2023;11(4):856.
Google Scholar
Gong W, Liang Y, Wang J, Liu Y, Xue Y, Mi J, et al. Prediction of Th1 and cytotoxic T lymphocyte epitopes of Mycobacterium tuberculosis and evaluation of their potential in the diagnosis of tuberculosis in a mouse model and in humans. Microbiol Spectr. 2022;10(4):e0143822.
Google Scholar
Liu X, Li F, Niu H, Ma L, Chen J, Zhang Y, et al. IL-2 restores T-Cell dysfunction induced by persistent Mycobacterium tuberculosis antigen stimulation. Front Immunol. 2019;10:2350.
Google Scholar
Lombardi A, Villa S, Castelli V, Bandera A, Gori A. T-cell exhaustion in Mycobacterium tuberculosis and nontuberculous mycobacteria infection: pathophysiology and therapeutic perspectives. Microorganisms. 2021;9(12):2460.
Google Scholar
Pan J, Zhang X, Xu J, Chang Z, Xin Z, Wang G. Landscape of exhausted T cells in tuberculosis revealed by single-cell sequencing. Microbiol Spectr. 2023;11(2):e0283922.
Google Scholar
Qin Y, Wang Q, Shi J. Immune checkpoint modulating T cells and NK cells response to Mycobacterium tuberculosis infection. Microbiol Res. 2023;273:127393.
Google Scholar
Suarez GV, Melucci Ganzarain CDC, Vecchione MB, Trifone CA, Marin Franco JL, Genoula M, et al. PD-1/PD-L1 pathway modulates macrophage susceptibility to Mycobacterium tuberculosis specific CD8+ T cell induced death. Sci Rep. 2019;9(1):187.
Google Scholar
Jayaraman P, Jacques MK, Zhu C, Steblenko KM, Stowell BL, Madi A, et al. TIM3 mediates T cell exhaustion during Mycobacterium tuberculosis infection. PLoS Pathog. 2016;12(3):e1005490.
Google Scholar
Wykes MN, Lewin SR. Immune checkpoint blockade in infectious diseases. Nat Rev Immunol. 2018;18(2):91–104.
Google Scholar
Phillips BL, Gautam US, Bucsan AN, Foreman TW, Golden NA, Niu T, et al. LAG-3 potentiates the survival of Mycobacterium tuberculosis in host phagocytes by modulating mitochondrial signaling in an in-vitro granuloma model. PLoS One. 2017;12(9):e0180413.
Google Scholar
Hougardy JM, Verscheure V, Locht C, Mascart F. In vitro expansion of CD4+CD25highFOXP3+CD127low/- regulatory T cells from peripheral blood lymphocytes of healthy Mycobacterium tuberculosis-infected humans. Microbes Infect. 2007;9(11):1325–32.
Google Scholar
Rao M, Valentini D, Dodoo E, Zumla A, Maeurer M. Anti-PD-1/PD-L1 therapy for infectious diseases: learning from the cancer paradigm. Int J Infect Dis. 2017;56:221–8.
Google Scholar
Liu L, Song Z, Xun J, Liu D, Wei J, Wang Z, et al. PD-1 inhibitor for disseminated Mycobacterium avium infection in a person with HIV. Open Forum Infect Dis. 2023;10(1):ofac700.
Google Scholar
Glatman-Freedman A, Casadevall A. Serum therapy for tuberculosis revisited: reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis. Clin Microbiol Rev. 1998;11(3):514–32.
Google Scholar
Seder RA, Hill AV. Vaccines against intracellular infections requiring cellular immunity. Nature. 2000;406(6797):793–8.
Google Scholar
Lund FE, Randall TD. Effector and regulatory B cells: modulators of CD4+ T cell immunity. Nat Rev Immunol. 2010;10(4):236–47.
Google Scholar
Chan J, Mehta S, Bharrhan S, Chen Y, Achkar JM, Casadevall A, et al. The role of B cells and humoral immunity in Mycobacterium tuberculosis infection. Semin Immunol. 2014;26(6):588–600.
Google Scholar
Bayry J, Lacroix-Desmazes S, Kazatchkine MD, Hermine O, Tough DF, Kaveri SV. Modulation of dendritic cell maturation and function by B lymphocytes. J Immunol. 2005;175(1):15.
Google Scholar
Mauri C, Bosma A. Immune regulatory function of B cells. Annu Rev Immunol. 2012;30:221.
Google Scholar
Ahmed R, Gray D. Immunological memory and protective immunity: understanding their relation. Science. 1996;272(5258):54–60.
Google Scholar
Harris DP, Haynes L, Sayles PC, Duso DK, Eaton SM, Lepak NM, et al. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol. 2000;1(6):475–82.
Google Scholar
Bai XF, Zhu J, Zhang GX, Kaponides G, Höjeberg B, van der Meide PH, et al. IL-10 suppresses experimental autoimmune neuritis and down-regulates TH1-type immune responses. Clin Immunol Immunopathol. 1997;83(2):117–26.
Google Scholar
Cañete PF, Sweet RA, Gonzalez-Figueroa P, Papa I, Ohkura N, Bolton H, et al. Regulatory roles of IL-10-producing human follicular T cells. J Exp Med. 2019;216(8):1843–56.
Google Scholar
Zhuang L, Ye Z, Li L, Yang L, Gong W. Next-generation TB vaccines: progress, challenges, and prospects. Vaccines. 2023;11(8):1304.
Google Scholar
Yang L, Zhuang L, Ye Z, Li L, Guan J, Gong W. Immunotherapy and biomarkers in patients with lung cancer with tuberculosis: recent advances and future directions. iScience. 2023;26(10):107881.
Google Scholar
Choe J, Choi YS. IL-10 interrupts memory B cell expansion in the germinal center by inducing differentiation into plasma cells. Eur J Immunol. 1998;28(2):508–15.
Google Scholar
Loxton AG. B cells and their regulatory functions during tuberculosis: latency and active disease. Mol Immunol. 2019;111:145–51.
Google Scholar
Wolf SD, Dittel BN, Hardardottir F, Janeway CA Jr. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med. 1996;184(6):2271–8.
Google Scholar
Sun J, Basu U. Purification of murine IL-10+ B cells for analyses of biological functions and transcriptomics. Methods Mol Biol. 2021;2270:307–21.
Google Scholar
Roy E, Stavropoulos E, Brennan J, Coade S, Grigorieva E, Walker B, et al. Therapeutic efficacy of high-dose intravenous immunoglobulin in Mycobacterium tuberculosis infection in mice. Infect Immun. 2005;73(9):6101–9.
Google Scholar
Olivares N, Marquina B, Mata-Espinoza D, Zatarain-Barron ZL, Pinzón CE, Estrada I, et al. The protective effect of immunoglobulin in murine tuberculosis is dependent on IgG glycosylation. Pathog Dis. 2013;69(3):176–83.
Google Scholar
Li H, Wang XX, Wang B, Fu L, Liu G, Lu Y, et al. Latently and uninfected healthcare workers exposed to TB make protective antibodies against Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 2017;114(19):5023–8.
Google Scholar
Andrews JR, Noubary F, Walensky RP, Cerda R, Losina E, Horsburgh CR. Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis. Clin Infect Dis. 2012;54(6):784–91.
Google Scholar
Lu LL, Chung AW, Rosebrock TR, Ghebremichael M, Yu WH, Grace PS, et al. A functional role for antibodies in tuberculosis. Cell. 2016;167(2):433-43.e14.
Google Scholar
Achkar JM, Prados-Rosales R. Updates on antibody functions in Mycobacterium tuberculosis infection and their relevance for developing a vaccine against tuberculosis. Curr Opin Immunol. 2018;53:30–7.
Google Scholar
Bournazos S, Ravetch JV. Fcγ receptor function and the design of vaccination strategies. Immunity. 2017;47(2):224–33.
Google Scholar
Faridgohar M, Nikoueinejad H. New findings of Toll-like receptors involved in Mycobacterium tuberculosis infection. Pathog Glob Health. 2017;111(5):256–64.
Google Scholar
Zhou Y, Zhang M. Associations between genetic polymorphisms of TLRs and susceptibility to tuberculosis: a meta-analysis. Innate Immun. 2020;26(2):75–83.
Google Scholar
Varshney D, Singh S, Sinha E, Mohanty KK, Kumar S, Kumar Barik S, et al. Systematic review and meta-analysis of human Toll-like receptors genetic polymorphisms for susceptibility to tuberculosis infection. Cytokine. 2022;152:155791.
Google Scholar
Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124(4):783–801.
Google Scholar
Barton GM, Kagan JC. A cell biological view of Toll-like receptor function: regulation through compartmentalization. Nat Rev Immunol. 2009;9(8):535–42.
Google Scholar
Wang L, Xiong Y, Fu B, Guo D, Zaky MY, Lin X, et al. MicroRNAs as immune regulators and biomarkers in tuberculosis. Front Immunol. 2022;13:1027472.
Google Scholar
Kleinnijenhuis J, Oosting M, Joosten LA, Netea MG, Van Crevel R. Innate immune recognition of Mycobacterium tuberculosis. Clin Dev Immunol. 2011;2011:405310.
Google Scholar
Reiling N, Hölscher C, Fehrenbach A, Kröger S, Kirschning CJ, Goyert S, et al. Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J Immunol. 2002;169(7):3480–4.
Google Scholar
Abel B, Thieblemont N, Quesniaux VJ, Brown N, Mpagi J, Miyake K, et al. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J Immunol. 2002;169(6):3155–62.
Google Scholar
Pahari S, Negi S, Aqdas M, Arnett E, Schlesinger LS, Agrewala JN. Induction of autophagy through CLEC4E in combination with TLR4: an innovative strategy to restrict the survival of Mycobacterium tuberculosis. Autophagy. 2020;16(6):1021–43.
Google Scholar
Gopalakrishnan A, Salgame P. Toll-like receptor 2 in host defense against Mycobacterium tuberculosis: to be or not to be-that is the question. Curr Opin Immunol. 2016;42:76–82.
Google Scholar
Drennan MB, Nicolle D, Quesniaux VJ, Jacobs M, Allie N, Mpagi J, et al. Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection. Am J Pathol. 2004;164(1):49–57.
Google Scholar
López M, Sly LM, Luu Y, Young D, Cooper H, Reiner NE. The 19-kDa Mycobacterium tuberculosis protein induces macrophage apoptosis through Toll-like receptor-2. J Immunol. 2003;170(5):2409–16.
Google Scholar
Guo XG, Xia Y. The rs5743708 gene polymorphism in the TLR2 gene contributes to the risk of tuberculosis disease. Int J Clin Exp Pathol. 2015;8(9):11921–8.
Google Scholar
Netea MG, Van der Meer JW, Kullberg BJ. Toll-like receptors as an escape mechanism from the host defense. Trends Microbiol. 2004;12(11):484–8.
Google Scholar
Saraav I, Singh S, Sharma S. Outcome of Mycobacterium tuberculosis and Toll-like receptor interaction: immune response or immune evasion?. Immunol Cell Biol. 2014;92(9):741–6.
Google Scholar
Bafica A, Scanga CA, Feng CG, Leifer C, Cheever A, Sher A. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J Exp Med. 2005;202(12):1715–24.
Google Scholar
Pompei L, Jang S, Zamlynny B, Ravikumar S, McBride A, Hickman SP, et al. Disparity in IL-12 release in dendritic cells and macrophages in response to Mycobacterium tuberculosis is due to use of distinct TLRs. J Immunol. 2007;178(8):5192–9.
Google Scholar
Nguyen H, Gazy N, Venketaraman V. A role of intracellular Toll-like receptors (3, 7, and 9) in response to Mycobacterium tuberculosis and co-infection with HIV. Int J Mol Sci. 2020;21(17):6148.
Google Scholar
Coelho da Silva FD, Covre LP, Stringari LL, Palaci M, Dietze R, Gomes DCO, et al. Toll-like receptors blocking restores in vitro microbicidal activity in latent tuberculosis-infected subjects. Int J Tuberc Lung Dis. 2019;23(2):212–8.
Google Scholar
Stenger S, Modlin RL. Control of Mycobacterium tuberculosis through mammalian Toll-like receptors. Curr Opin Immunol. 2002;14(4):452–7.
Google Scholar
Kleinnijenhuis J, Joosten LA, van de Veerdonk FL, Savage N, van Crevel R, Kullberg BJ, et al. Transcriptional and inflammasome-mediated pathways for the induction of IL-1beta production by Mycobacterium tuberculosis. Eur J Immunol. 2009;39(7):1914–22.
Google Scholar
Means TK, Jones BW, Schromm AB, Shurtleff BA, Smith JA, Keane J, et al. Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses. J Immunol. 2001;166(6):4074–82.
Google Scholar
Chandra P, Grigsby SJ, Philips JA. Immune evasion and provocation by Mycobacterium tuberculosis. Nat Rev Microbiol. 2022;20(12):750–66.
Google Scholar
Migliori GB, Ong CWM, Petrone L, D’Ambrosio L, Centis R, Goletti D. The definition of tuberculosis infection based on the spectrum of tuberculosis disease. Breathe (Sheff). 2021;17(3):210079.
Google Scholar
Drain PK, Bajema KL, Dowdy D, Dheda K, Naidoo K, Schumacher SG, et al. Incipient and subclinical tuberculosis: a clinical review of early stages and progression of infection. Clin Microbiol Rev. 2018;31(4):e00021-18.
Google Scholar
Achkar JM, Jenny-Avital ER. Incipient and subclinical tuberculosis: defining early disease states in the context of host immune response. J Infect Dis. 2011;204 Suppl 4(Suppl 4):S1179–86.
Google Scholar
Manca C, Tsenova L, Bergtold A, Freeman S, Tovey M, Musser JM, et al. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta. Proc Natl Acad Sci U S A. 2001;98(10):5752–7.
Google Scholar
Olson GS, Murray TA, Jahn AN, Mai D, Diercks AH, Gold ES, et al. Type I interferon decreases macrophage energy metabolism during mycobacterial infection. Cell Rep. 2021;35(9):109195.
Google Scholar
Dabla A, Liang YC, Rajabalee N, Irwin C, Moonen CGJ, Willis JV, et al. TREM2 promotes immune evasion by Mycobacterium tuberculosis in Human Macrophages. MBio. 2022;13(4):e0145622.
Google Scholar
Parveen N, Varman R, Nair S, Das G, Ghosh S, Mukhopadhyay S. Endocytosis of Mycobacterium tuberculosis heat shock protein 60 is required to induce interleukin-10 production in macrophages. J Biol Chem. 2013;288(34):24956–71.
Google Scholar
Pathak SK, Basu S, Basu KK, Banerjee A, Pathak S, Bhattacharyya A, et al. Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages. Nat Immunol. 2007;8(6):610–8.
Google Scholar
Srivastava S, Grace PS, Ernst JD. Antigen export reduces antigen presentation and limits T cell control of M. tuberculosis. Cell Host Microbe. 2016;19(1):44–54.
Google Scholar
Portal-Celhay C, Tufariello JM, Srivastava S, Zahra A, Klevorn T, Grace PS, et al. Mycobacterium tuberculosis EsxH inhibits ESCRT-dependent CD4+ T-cell activation. Nat Microbiol. 2016;2:16232.
Google Scholar
Georgieva M, Sia JK, Bizzell E, Madan-Lala R, Rengarajan J. Mycobacterium tuberculosis GroEL2 modulates dendritic cell responses. Infect Immun. 2018;86(2):e00387-e417.
Google Scholar
Liu CH, Liu H, Ge B. Innate immunity in tuberculosis: host defense vs pathogen evasion. Cell Mol Immunol. 2017;14(12):963–75.
Google Scholar
Chai Q, Wang L, Liu CH, Ge B. New insights into the evasion of host innate immunity by Mycobacterium tuberculosis. Cell Mol Immunol. 2020;17(9):901–13.
Google Scholar
Yang J, Zhang L, Qiao W, Luo Y. Mycobacterium tuberculosis: pathogenesis and therapeutic targets. MedComm. 2023;4(5):e353.
Google Scholar
Clemens DL, Horwitz MA. Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. J Exp Med. 1995;181(1):257–70.
Google Scholar
Stewart GR, Patel J, Robertson BD, Rae A, Young DB. Mycobacterial mutants with defective control of phagosomal acidification. PLoS Pathog. 2005;1(3):269–78.
Google Scholar
Rohde K, Yates RM, Purdy GE, Russell DG. Mycobacterium tuberculosis and the environment within the phagosome. Immunol Rev. 2007;219:37–54.
Google Scholar
Schaible UE, Sturgill-Koszycki S, Schlesinger PH, Russell DG. Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages. J Immunol. 1998;160(3):1290–6.
Google Scholar
Khare G, Reddy PV, Sidhwani P, Tyagi AK. KefB inhibits phagosomal acidification but its role is unrelated to M. tuberculosis survival in host. Sci Rep. 2013;3:35270.
Google Scholar
van der Wel N, Hava D, Houben D, Fluitsma D, van Zon M, Pierson J, et al. M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells. Cell. 2007;129(7):1287–98.
Google Scholar
Simeone R, Bobard A, Lippmann J, Bitter W, Majlessi L, Brosch R, et al. Phagosomal rupture by Mycobacterium tuberculosis results in toxicity and host cell death. PLoS Pathog. 2012;8(2):e1002507.
Google Scholar
Herrera MT, Guzman-Beltran S, Bobadilla K, Santos-Mendoza T, Flores-Valdez MA, Gutierrez-Gonzalez LH, et al. Human pulmonary tuberculosis: understanding the immune response in the bronchoalveolar system. Biomolecules. 2022;12:8.
Google Scholar
Abramovitch RB, Rohde KH, Hsu FF, Russell DG. aprABC: a Mycobacterium tuberculosis complex-specific locus that modulates pH-driven adaptation to the macrophage phagosome. Mol Microbiol. 2011;80(3):678–94.
Google Scholar
Pethe K, Swenson DL, Alonso S, Anderson J, Wang C, Russell DG. Isolation of Mycobacterium tuberculosis mutants defective in the arrest of phagosome maturation. Proc Natl Acad Sci U S A. 2004;101(37):13642–7.
Google Scholar
Kishi-Itakura C, Koyama-Honda I, Itakura E, Mizushima N. Ultrastructural analysis of autophagosome organization using mammalian autophagy-deficient cells. J Cell Sci. 2014;127(Pt 18):4089–102.
Google Scholar
Zhou J, Lv J, Carlson C, Liu H, Wang H, Xu T, et al. Trained immunity contributes to the prevention of Mycobacterium tuberculosis infection, a novel role of autophagy. Emerg Microbes Infect. 2021;10(1):578–88.
Google Scholar
Dutta RK, Kathania M, Raje M, Majumdar S. IL-6 inhibits IFN-gamma induced autophagy in Mycobacterium tuberculosis H37Rv infected macrophages. Int J Biochem Cell Biol. 2012;44(6):942.
Google Scholar
Singh R, Kaushik S, Wang Y, Xiang Y, Novak I, Komatsu M, et al. Autophagy regulates lipid metabolism. Nature. 2009;458(7242):1131–5.
Google Scholar
Guo L, Zhao J, Qu Y, Yin R, Gao Q, Ding S, et al. microRNA-20a inhibits autophagic process by targeting ATG7 and ATG16L1 and favors mycobacterial survival in macrophage cells. Front Cell Infect Microbiol. 2016;6:134.
Google Scholar
Gu X, Gao Y, Mu DG, Fu EQ. MiR-23a-5p modulates mycobacterial survival and autophagy during Mycobacterium tuberculosis infection through TLR2/MyD88/NF-kappaB pathway by targeting TLR2. Exp Cell Res. 2017;354(2):71–7.
Google Scholar
Padhi A, Pattnaik K, Biswas M, Jagadeb M, Behera A, Sonawane A. Mycobacterium tuberculosis LprE suppresses TLR2-dependent cathelicidin and autophagy expression to enhance bacterial survival in macrophages. J Immunol. 2019;203(10):2665–78.
Google Scholar
Srinivasan L, Ahlbrand S, Briken V. Interaction of Mycobacterium tuberculosis with host cell death pathways. Cold Spring Harb Perspect Med. 2014;4(8):a022459.
Google Scholar
Wang J, Teng JL, Zhao D, Ge P, Li B, Woo PC, et al. The ubiquitin ligase TRIM27 functions as a host restriction factor antagonized by Mycobacterium tuberculosis PtpA during mycobacterial infection. Sci Rep. 2016;6:34827.
Google Scholar
Velmurugan K, Chen B, Miller JL, Azogue S, Gurses S, Hsu T, et al. Mycobacterium tuberculosis nuoG is a virulence gene that inhibits apoptosis of infected host cells. PLoS Pathog. 2007;3(7):e110.
Google Scholar
Dutta NK, Mehra S, Martinez AN, Alvarez X, Renner NA, Morici LA, et al. The stress-response factor SigH modulates the interaction between Mycobacterium tuberculosis and host phagocytes. PLoS One. 2012;7(1):e28958.
Google Scholar
Wang Q, Liu S, Tang Y, Liu Q, Yao Y. MPT64 protein from Mycobacterium tuberculosis inhibits apoptosis of macrophages through NF-κB-miRNA21-Bcl-2 pathway. PLoS One. 2014;9(7):e100949.
Google Scholar
Rojas M, Olivier M, Gros P, Barrera LF, Garcia LF. TNF-alpha and IL-10 modulate the induction of apoptosis by virulent Mycobacterium tuberculosis in murine macrophages. J Immunol. 1999;162(10):6122–31.
Google Scholar
Lee J, Hartman M, Kornfeld H. Macrophage apoptosis in tuberculosis. Yonsei Med J. 2009;50(1):1–11.
Google Scholar
Bloch H, Segal W. Biochemical differentiation of Mycobacterium tuberculosis grown in vivo and in vitro. J Bacteriol. 1956;72(2):132–41.
Google Scholar
Lee W, VanderVen BC, Fahey RJ, Russell DG. Intracellular Mycobacterium tuberculosis exploits host-derived fatty acids to limit metabolic stress. J Biol Chem. 2013;288(10):6788–800.
Google Scholar
Savvi S, Warner DF, Kana BD, McKinney JD, Mizrahi V, Dawes SS. Functional characterization of a vitamin B12-dependent methylmalonyl pathway in Mycobacterium tuberculosis: implications for propionate metabolism during growth on fatty acids. J Bacteriol. 2008;190(11):3886–95.
Google Scholar
Voynikov Y, Valcheva V, Momekov G, Peikov P, Stavrakov G. Theophylline-7-acetic acid derivatives with amino acids as anti-tuberculosis agents. Bioorg Med Chem Lett. 2014;24(14):3043.
Google Scholar
Shukla R, Shukla H, Tripathi T. Structural and energetic understanding of novel natural inhibitors of Mycobacterium tuberculosis malate synthase. J Cell Biochem. 2019;120(2):2469–82.
Google Scholar
Antil M, Gupta V. Lessons learnt and the way forward for drug development against isocitrate lyase from Mycobacterium tuberculosis. Protein Pept Lett. 2022;29(12):1031–41.
Google Scholar
Puckett S, Trujillo C, Wang Z, Eoh H, Ioerger TR, Krieger I, et al. Glyoxylate detoxification is an essential function of malate synthase required for carbon assimilation in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 2017;114(11):E2225–32.
Google Scholar
Munoz-Elias EJ, McKinney JD. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nat Med. 2005;11(6):638–44.
Google Scholar
Blumenthal A, Trujillo C, Ehrt S, Schnappinger D. Simultaneous analysis of multiple Mycobacterium tuberculosis knockdown mutants in vitro and in vivo. PLoS One. 2010;5(12):e15667.
Google Scholar
Gengenbacher M, Rao SPS, Pethe K, Dick T. Nutrient-starved, non-replicating Mycobacterium tuberculosis requires respiration, ATP synthase and isocitrate lyase for maintenance of ATP homeostasis and viability. Microbiology. 2010;156(Pt 1):81–7.
Google Scholar
Noble D. Conrad Waddington and the origin of epigenetics. J Exp Biol. 2015;218(Pt 6):816–8.
Google Scholar
Bhavsar AP, Guttman JA, Finlay BB. Manipulation of host-cell pathways by bacterial pathogens. Nature. 2007;449(7164):827–34.
Google Scholar
Bobak CA, Abhimanyu NH, Gandhi T, Grimm SL, Nishiguchi T, et al. Increased DNA methylation, cellular senescence and premature epigenetic aging in guinea pigs and humans with tuberculosis. Aging. 2022;14(5):2174–93.
Google Scholar
Singh V, Prakhar P, Rajmani RS, Mahadik K, Borbora SM, Balaji KN. Histone methyltransferase SET8 epigenetically reprograms host immune responses to assist mycobacterial survival. J Infect Dis. 2017;216(4):477–88.
Google Scholar
Gurtan AM, Sharp PA. The role of miRNAs in regulating gene expression networks. J Mol Biol. 2013;425(19):3582–600.
Google Scholar
Hammond SM. An overview of microRNAs. Adv Drug Deliv Rev. 2015;87:3–14.
Google Scholar
Davalos A, Goedeke L, Smibert P, Ramirez CM, Warrier NP, Andreo U, et al. miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc Natl Acad Sci U S A. 2011;108(22):9232–7.
Google Scholar
Wang J, Yang K, Zhou L, Minhaowu WuY, Zhu M, et al. MicroRNA-155 promotes autophagy to eliminate intracellular mycobacteria by targeting Rheb. PLoS Pathog. 2013;9(10):e1003697.
Google Scholar
Niu W, Sun B, Li M, Cui J, Huang J, Zhang L. TLR-4/microRNA-125a/NF-kappaB signaling modulates the immune response to Mycobacterium tuberculosis infection. Cell Cycle. 2018;17(15):1931–45.
Google Scholar
Fu Y, Yi Z, Wu X, Li J, Xu F. Circulating microRNAs in patients with active pulmonary tuberculosis. J Clin Microbiol. 2011;49(12):4246–51.
Google Scholar
Angria N, Massi MN, Bukhari A, Djaharuddin I, Jumadi O, Ahmad A, et al. Expression of miRNA-29a-3p and IFN-gamma as biomarkers in active and latent pulmonary tuberculosis. Ann Med Surg. 2022;83:104786.
Google Scholar
Daniel EA, Sathiyamani B, Thiruvengadam K, Vivekanandan S, Vembuli H, Hanna LE. MicroRNAs as diagnostic biomarkers for tuberculosis: a systematic review and meta- analysis. Front Immunol. 2022;13:954396.
Google Scholar
Gualano G, Mencarini P, Lauria FN, Palmieri F, Mfinanga S, Mwaba P, et al. Tuberculin skin test – outdated or still useful for latent TB infection screening?. Int J Infect Dis. 2019;80S:S20–2.
Google Scholar
Maes M, Gimenez JF, D’Alessandro A, De Waard JH. The stability of human, bovine and avian tuberculin purified protein derivative (PPD). J Infect Dev Ctries. 2011;5(11):781–5.
Google Scholar
Hoff ST, Peter JG, Theron G, Pascoe M, Tingskov PN, Aggerbeck H, et al. Sensitivity of C-Tb: a novel RD-1-specific skin test for the diagnosis of tuberculosis infection. Eur Respir J. 2016;47(3):919–28.
Google Scholar
Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med. 2008;149(3):177–84.
Google Scholar
Doan TN, Eisen DP, Rose MT, Slack A, Stearnes G, McBryde ES. Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: a latent-class analysis. PLoS One. 2017;12(11):e0188631.
Google Scholar
Krutikov M, Faust L, Nikolayevskyy V, Hamada Y, Gupta RK, Cirillo D, et al. The diagnostic performance of novel skin-based in-vivo tests for tuberculosis infection compared with purified protein derivative tuberculin skin tests and blood-based in vitro interferon-gamma release assays: a systematic review and meta-analysis. Lancet Infect Dis. 2022;22(2):250–64.
Google Scholar
Starshinova A, Dovgalyk I, Malkova A, Zinchenko Y, Pavlova M, Belyaeva E, et al. Recombinant tuberculosis allergen Diaskintest® in tuberculosis diagnostic in Russia (meta-analysis). Int J Mycobacteriol. 2020;9(4):335–46.
Google Scholar
Zhang H, Wang L, Li F, Lu S, Xia J. Induration or erythema diameter not less than 5 mm as results of recombinant fusion protein ESAT6-CFP10 skin test for detecting M. tuberculosis infection. BMC Infect Dis. 2020;20(1):685.
Google Scholar
Kiselev VI, Baranovskii PM, Rudykh IV, Shuster AM, Mart’ianov VA, Mednikov BL, et al. Clinical trials of the new skin test Diaskintest for the diagnosis of tuberculosis. Probl Tuberk Bolezn Legk. 2009;2:11–6.
Starshinova A, Zhuravlev V, Dovgaluk I, Panteleev A, Manina V, Zinchenko U, et al. A comparison of intradermal test with recombinant tuberculosis allergen (diaskintest) with other immunologic tests in the diagnosis of tuberculosis infection. Int J Mycobacteriol. 2018;7(1):32–9.
Google Scholar
Xu M, Lu W, Li T, Li J, Du W, Wu Q, et al. Sensitivity, specificity, and safety of a novel ESAT6-CFP10 skin test for tuberculosis infection in China: 2 randomized, self-controlled, parallel-group phase 2b trials. Clin Infect Dis. 2022;74(4):668–77.
Google Scholar
Yang Y, Fang Z, Huang W, Zhang H, Luo S, Lin S, et al. Safety of a Novel ESAT6-CFP10 skin test compared with tuberculin skin test in a double-blind, randomized, controlled study. BMC Infect Dis. 2022;22(1):780.
Google Scholar
Lu P, Wu K, Zhou H, Yu H, Yuan J, Dong L, et al. Evaluation of ESAT6-CFP10 Skin test for Mycobacterium tuberculosis infection among persons living with HIV in China. J Clin Microbiol. 2023;61(4):e0181622.
Google Scholar
Oh CE, Ortiz-Brizuela E, Bastos ML, Menzies D. Comparing the diagnostic performance of QuantiFERON-TB Gold Plus to other tests of latent tuberculosis infection: a systematic review and meta-analysis. Clin Infect Dis. 2021;73(5):e1116–25.
Google Scholar
Altawallbeh G, Gabrielson D, Peters JM, Killeen AA. Performance of an advanced interferon-gamma release assay for Mycobacterium tuberculosis detection. J Appl Lab Med. 2021;6(5):1287.
Google Scholar
Kim JJ, Park Y, Choi D, Kim HS. Performance evaluation of a new automated chemiluminescent immunoanalyzer-based interferon-gamma releasing assay AdvanSure I3 in comparison with the QuantiFERON-TB Gold In-Tube assay. Ann Lab Med. 2020;40(1):33–9.
Google Scholar
Ortiz-Brizuela E, Apriani L, Mukherjee T, Lachapelle-Chisholm S, Miedy M, Lan Z, et al. Assessing the diagnostic performance of new commercial interferon-gamma release assays for Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Clin Infect Dis. 2023;76(11):1989–99.
Google Scholar
Jung J, Jhun BW, Jeong M, Yoon SJ, Huh HJ, Jung CW, et al. Is the new interferon-gamma releasing assay beneficial for the diagnosis of latent and active Mycobacterium tuberculosis infections in tertiary care setting?. J Clin Med. 2021;10(7):1376.
Google Scholar
Fukushima K, Akagi K, Kondo A, Kubo T, Sakamoto N, Mukae H. First clinical evaluation of the QIAreach™ QuantiFERON-TB for tuberculosis infection and active pulmonary disease. Pulmonology. 2022;28(1):6–12.
Google Scholar
Aziz ZA, Noordin NM, Wan Mohd WM, Kasim MA. First evaluation of the performance of portable IGRA, QIAreach® QuantiFERON®-TB in intermediate TB incidence setting. PLoS One. 2023;18(2):e0279882.
Google Scholar
Hur YG, Hong JY, Choi DH, Kim A, Park SY, Kwon M, et al. A feasibility study for diagnosis of latent tuberculosis infection using an IGRA Point-of-Care platform in South Korea. Yonsei Med J. 2019;60(4):375–80.
Google Scholar
Petruccioli E, Farroni C, Cuzzi G, Vanini V, Palmieri F, Vittozzi P, et al. VIDAS® TB-IGRA reagents induce a CD4(+) and CD8(+) T-cell IFN-gamma response for both TB infection and active TB. Int J Tuberc Lung Dis. 2022;26(1):65–8.
Google Scholar
Meier JP, Mobus S, Heigl F, Asbach-Nitzsche A, Niller HH, Plentz A, et al. Performance of T-Track® TB, a novel dual marker RT-qPCR-based whole-blood test for improved detection of active tuberculosis. Diagnostics. 2023;13(4):758.
Google Scholar
Zhu M, Zhu Z, Yang J, Hu K. Performance evaluation of IGRA-ELISA and T-SPOT.TB for diagnosing tuberculosis infection. Clin Lab. 2019. https://doi.org/10.7754/Clin.Lab.2019.181109.
Google Scholar
Pourakbari B, Mamishi S, Benvari S, Sauzullo I, Bedini A, Valentini P, et al. Can interferon-gamma release assays be useful for monitoring the response to anti-tuberculosis treatment?: a systematic review and meta-analysis. Arch Immunol Ther Exp. 2020;68(1):4.
Google Scholar
Kweon OJ, Lim YK, Kim HR, Kim TH, Lee MK. Evaluation of standard E TB-Feron enzyme-linked immunosorbent assay for diagnosis of latent tuberculosis infection in health care workers. J Clin Microbiol. 2019;57:12.
Google Scholar
Faust L, Ruhwald M, Schumacher S, Pai M. How are high burden countries implementing policies and tools for latent tuberculosis infection? A survey of current practices and barriers. Health Sci Rep. 2020;3(2):e158.
Google Scholar
Saluzzo F, Mantegani P, Poletti de Chaurand V, Cirillo DM. QIAreach QuantiFERON-TB for the diagnosis of Mycobacterium tuberculosis infection. Eur Respir J. 2022;59(3):2102563.
Google Scholar
Stieber F, Howard J, Manissero D, Boyle J, Ndunda N, Love J, et al. Evaluation of a lateral-flow nanoparticle fluorescence assay for TB infection diagnosis. Int J Tuberc Lung Dis. 2021;25(11):917–22.
Google Scholar
Kweon OJ, Lim YK, Kim HR, Kim TH, Lee MK. Performance evaluation of newly developed fluorescence immunoassay-based interferon-gamma release assay for the diagnosis of latent tuberculosis infection in healthcare workers. J Microbiol Immunol Infect. 2022;55(2):328–31.
Google Scholar
Lee HH, Choi DH, Kim JR, Kim YG, Jo KW, Shim TS. Evaluation of a lateral flow assay-based IFN-gamma release assay as a point-of-care test for the diagnosis of latent tuberculosis infection. Clin Rheumatol. 2021;40(9):3773–81.
Google Scholar
Petruccioli E, Chiacchio T, Pepponi I, Vanini V, Urso R, Cuzzi G, et al. First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus. J Infect. 2016;73(6):588–97.
Google Scholar
bioMérieux. bioMérieux announces the CE marking of TB IGRA® test on VIDAS®: biomerieux; 2021 [cited 2023 June 6]. Available from: https://www.biomerieux.com/corp/en/journalists/press-releases/biomerieux-announces-ce-marking-tb-igrar-test-vidasr.html.
Hrizi O, Gasmi K, Ben Ltaifa I, Alshammari H, Karamti H, Krichen M, et al. Tuberculosis disease diagnosis based on an optimized machine learning model. J Healthc Eng. 2022;2022:8950243.
Google Scholar
Singh M, Pujar GV, Kumar SA, Bhagyalalitha M, Akshatha HS, Abuhaija B, et al. Evolution of machine learning in tuberculosis diagnosis: a review of deep learning-based medical applications. Electronics. 2022;11(17):2634.
Google Scholar
Xing Z, Ding W, Zhang S, Zhong L, Wang L, Wang J, et al. Machine learning-based differentiation of nontuberculous mycobacteria lung disease and pulmonary tuberculosis using CT images. Biomed Res Int. 2020;2020:6287545.
Google Scholar
Winkler DA. The impact of machine learning on future tuberculosis drug discovery. Expert Opin Drug Discov. 2022;17(9):925–7.
Google Scholar
Lane T, Russo DP, Zorn KM, Clark AM, Korotcov A, Tkachenko V, et al. Comparing and validating machine learning models for Mycobacterium tuberculosis drug discovery. Mol Pharm. 2018;15(10):4346–60.
Google Scholar
Yang F, Yu H, Kantipudi K, Karki M, Kassim YM, Rosenthal A, et al. Differentiating between drug-sensitive and drug-resistant tuberculosis with machine learning for clinical and radiological features. Quant Imaging Med Surg. 2022;12(1):675–87.
Google Scholar
Hu X, Wang J, Ju Y, Zhang X, Qimanguli W, Li C, et al. Combining metabolome and clinical indicators with machine learning provides some promising diagnostic markers to precisely detect smear-positive/negative pulmonary tuberculosis. BMC Infect Dis. 2022;22(1):707.
Google Scholar
Jaya F, Pushpa G, Mohan N, Ram D, Chauhan DS, Katoch VM, et al. Mycobacterium indicus praniias stand-alone or adjunct immunotherapeutic in treatment of experimental animal tuberculosis. Indian J Med Res. 2011;134(5):696–703.
Google Scholar
Jordan MI, Mitchell TM. Machine learning: trends, perspectives, and prospects. Science. 2015;349(6245):255–60.
Google Scholar
Wu WT, Li YJ, Feng AZ, Li L, Huang T, Xu AD, et al. Data mining in clinical big data: the frequently used databases, steps, and methodological models. Mil Med Res. 2021;8(1):44.
Google Scholar
Greener JG, Kandathil SM, Moffat L, Jones DT. A guide to machine learning for biologists. Nat Rev Mol Cell Biol. 2022;23(1):40–55.
Google Scholar
Gupta R, Srivastava D, Sahu M, Tiwari S, Ambasta RK, Kumar P. Artificial intelligence to deep learning: machine intelligence approach for drug discovery. Mol Divers. 2021;25(3):1315–60.
Google Scholar
Lo Vercio L, Amador K, Bannister JJ, Crites S, Gutierrez A, MacDonald ME, et al. Supervised machine learning tools: a tutorial for clinicians. J Neural Eng. 2020;17(6):062001.
Google Scholar
Bastanlar Y, Ozuysal M. Introduction to machine learning. Methods Mol Biol. 2014;1107:105.
Google Scholar
Deo RC. Machine learning in medicine. Circulation. 2015;132(20):1920–30.
Google Scholar
Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet. 2009;10(1):57–63.
Google Scholar
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.
Google Scholar
Mantione KJ, Kream RM, Kuzelova H, Ptacek R, Raboch J, Samuel JM, et al. Comparing bioinformatic gene expression profiling methods: microarray and RNA-Seq. Med Sci Monit Basic Res. 2014;20:138–42.
Google Scholar
Lee SW, Wu LS, Huang GM, Huang KY, Lee TY, Weng JT. Gene expression profiling identifies candidate biomarkers for active and latent tuberculosis. BMC Bioinformatics. 2016;17 Suppl 1(Suppl 1):3.
Google Scholar
Lu C, Wu J, Wang H, Wang S, Diao N, Wang F, et al. Novel biomarkers distinguishing active tuberculosis from latent infection identified by gene expression profile of peripheral blood mononuclear cells. PLoS One. 2011;6(8):e24290.
Google Scholar
Wang S, He L, Wu J, Zhou Z, Gao Y, Chen J, et al. Transcriptional profiling of human peripheral blood mononuclear cells identifies diagnostic biomarkers that distinguish active and latent tuberculosis. Front Immunol. 2019;10:2948.
Google Scholar
Maertzdorf J, McEwen G, Weiner J 3rd, Tian S, Lader E, Schriek U, et al. Concise gene signature for point-of-care classification of tuberculosis. EMBO Mol Med. 2016;8(2):86–95.
Google Scholar
Bayaa R, Ndiaye MDB, Chedid C, Kokhreidze E, Tukvadze N, Banu S, et al. Multi-country evaluation of RISK6, a 6-gene blood transcriptomic signature, for tuberculosis diagnosis and treatment monitoring. Sci Rep. 2021;11(1):13646.
Google Scholar
Gong Z, Gu Y, Xiong K, Niu J, Zheng R, Su B, et al. The evaluation and validation of blood-derived novel biomarkers for precise and rapid diagnosis of tuberculosis in areas with high-TB burden. Front Microbiol. 2021;12:650567.
Google Scholar
Kawka M, Dawidziuk A, Jiao LR, Gall TMH. Artificial intelligence in the detection, characterisation and prediction of hepatocellular carcinoma: a narrative review. Transl Gastroenterol Hepatol. 2022;7:41.
Google Scholar
Rajput D, Wang WJ, Chen CC. Evaluation of a decided sample size in machine learning applications. BMC Bioinf. 2023;24(1):48.
Google Scholar
Armstrong RA. Is there a large sample size problem?. Ophthalmic Physiol Opt. 2019;39(3):129–30.
Google Scholar
Goldenholz DM, Sun H, Ganglberger W, Westover MB. Sample size analysis for machine learning clinical validation studies. Biomedicines. 2023;11(3):685.
Google Scholar
Howard BE, Hu Q, Babaoglu AC, Chandra M, Borghi M, Tan X, et al. High-throughput RNA sequencing of pseudomonas-infected Arabidopsis reveals hidden transcriptome complexity and novel splice variants. PLoS One. 2013;8(10):e74183.
Google Scholar
Zhou Z, Zhou X, Cheng L, Wen L, An T, Gao H, et al. Machine learning algorithms utilizing blood parameters enable early detection of immunethrombotic dysregulation in COVID-19. Clin Transl Med. 2021;11(9):e523.
Google Scholar
Chang X, Zheng Y, Xu K. Single-cell RNA sequencing: technological progress and biomedical application in cancer research. Mol Biotechnol. 2023. https://doi.org/10.1007/s12033-023-00777-0.
Google Scholar
Wang Y, Wang JY, Schnieke A, Fischer K. Advances in single-cell sequencing: insights from organ transplantation. Mil Med Res. 2021;8(1):45.
Google Scholar
Su M, Pan T, Chen QZ, Zhou WW, Gong Y, Xu G, et al. Data analysis guidelines for single-cell RNA-seq in biomedical studies and clinical applications. Mil Med Res. 2022;9(1):68.
Google Scholar
Li PH, Kong XY, He YZ, Liu Y, Peng X, Li ZH, et al. Recent developments in application of single-cell RNA sequencing in the tumour immune microenvironment and cancer therapy. Mil Med Res. 2022;9(1):52.
Google Scholar
Chen Q, Hu C, Lu W, Hang T, Shao Y, Chen C, et al. Characteristics of alveolar macrophages in bronchioalveolar lavage fluids from active tuberculosis patients identified by single-cell RNA sequencing. J Biomed Res. 2022;36(3):167–80.
Google Scholar
Bossel Ben-Moshe N, Hen-Avivi S, Levitin N, Yehezkel D, Oosting M, Joosten LAB, et al. Predicting bacterial infection outcomes using single cell RNA-sequencing analysis of human immune cells. Nat Commun. 2019;10(1):3266.
Google Scholar
Hen-Avivi S, Avraham R. Immune cell type ‘fingerprints’ at the basis of outcome diversity of human infection. Curr Opin Microbiol. 2018;42:31–9.
Google Scholar
Cai Y, Dai Y, Wang Y, Yang Q, Guo J, Wei C, et al. Single-cell transcriptomics of blood reveals a natural killer cell subset depletion in tuberculosis. EBioMedicine. 2020;53:102686.
Google Scholar
Xu Y, Tan Y, Zhang X, Cheng M, Hu J, Liu J, et al. Comprehensive identification of immuno-related transcriptional signature for active pulmonary tuberculosis by integrated analysis of array and single cell RNA-seq. J Infect. 2022;85(5):534–44.
Google Scholar
Villaseñor-Altamirano AB, Jain D, Jeong Y, Menon JA, Kamiya M, Haider H, et al. Activation of CD8+ T cells in COPD lung. Am J Respir Crit Care Med. 2023. https://doi.org/10.1164/rccm.202305-0924OC.
Google Scholar
Huang L, Zhong L, Cheng R, Chang L, Qin M, Liang H, et al. Ferroptosis and WDFY4 as novel targets for immunotherapy of lung adenocarcinoma. Aging. 2023;15(18):9676.
Google Scholar
Luo G, Gao Q, Zhang S, Yan B. Probing infectious disease by single-cell RNA sequencing: progresses and perspectives. Comput Struct Biotechnol J. 2020;18:2962–71.
Google Scholar
Geraldes I, Fernandes M, Fraga AG, Osório NS. The impact of single-cell genomics on the field of mycobacterial infection. Front Microbiol. 2022;13:989464.
Google Scholar
Li Z, Hu J, Liu P, Cui D, Di H, Wu S. Microarray-based selection of a serum biomarker panel that can discriminate between latent and active pulmonary TB. Sci Rep. 2021;11(1):14516.
Google Scholar
Li J, Wang Y, Yan L, Zhang C, He Y, Zou J, et al. Novel serological biomarker panel using protein microarray can distinguish active TB from latent TB infection. Microbes Infect. 2022;24(8):105002.
Google Scholar
Cao SH, Chen YQ, Sun Y, Liu Y, Zheng SH, Zhang ZG, et al. Screening of serum biomarkers for distinguishing between latent and active tuberculosis using proteome microarray. Biomed Environ Sci. 2018;31(7):515–26.
Google Scholar
Peng Z, Chen L, Zhang H. Serum proteomic analysis of Mycobacterium tuberculosis antigens for discriminating active tuberculosis from latent infection. J Int Med Res. 2020;48(3):300060520910042.
Google Scholar
Delemarre EM, van Hoorn L, Bossink AWJ, Drylewicz J, Joosten SA, Ottenhoff THM, et al. Serum biomarker profile including CCL1, CXCL10, VEGF, and adenosine deaminase activity distinguishes active from remotely acquired latent tuberculosis. Front Immunol. 2021;12:725447.
Google Scholar
Luo Y, Xue Y, Liu W, Song H, Huang Y, Tang G, et al. Development of diagnostic algorithm using machine learning for distinguishing between active tuberculosis and latent tuberculosis infection. BMC Infect Dis. 2022;22(1):965.
Google Scholar
Morris TC, Hoggart CJ, Chegou NN, Kidd M, Oni T, Goliath R, et al. Evaluation of host serum protein biomarkers of tuberculosis in sub-Saharan Africa. Front Immunol. 2021;12:639174.
Google Scholar
Agranoff D, Fernandez-Reyes D, Papadopoulos MC, Rojas SA, Herbster M, Loosemore A, et al. Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet. 2006;368(9540):1012–21.
Google Scholar
Luo J, Zhang M, Yan B, Li F, Guan S, Chang K, et al. Diagnostic performance of plasma cytokine biosignature combination and MCP-1 as individual biomarkers for differentiating stages Mycobacterium tuberculosis infection. J Infect. 2019;78(4):281–91.
Google Scholar
Li H, Liu L, Zhang WJ, Zhang X, Zheng J, Li L, et al. Analysis of the antigenic properties of membrane proteins of Mycobacterium tuberculosis. Sci Rep. 2019;9(1):3042.
Google Scholar
Giannini HM, Ginestra JC, Chivers C, Draugelis M, Hanish A, Schweickert WD, et al. A machine learning algorithm to predict severe sepsis and septic shock: development, implementation, and impact on clinical practice. Crit Care Med. 2019;47(11):1485–92.
Google Scholar
Ngiam KY, Khor IW. Big data and machine learning algorithms for health-care delivery. Lancet Oncol. 2019;20(5):e262–73.
Google Scholar
Dey D, Slomka PJ, Leeson P, Comaniciu D, Shrestha S, Sengupta PP, et al. Artificial intelligence in cardiovascular imaging: JACC State-of-the-Art review. J Am Coll Cardiol. 2019;73(11):1317–35.
Google Scholar
Li D, Dong Y. Deep learning: methods and applications. Hanover: Now Foundations and Trends Publishers; 2014.
Majnarić LT, Babič F, O’Sullivan S, Holzinger A. AI and big data in healthcare: towards a more comprehensive research framework for multimorbidity. J Clin Med. 2021;10(4):766.
Google Scholar
Ting DSW, Pasquale LR, Peng L, Campbell JP, Lee AY, Raman R, et al. Artificial intelligence and deep learning in ophthalmology. Br J Ophthalmol. 2019;103(2):167–75.
Google Scholar
Jiang F, Jiang Y, Zhi H, Dong Y, Li H, Ma S, et al. Artificial intelligence in healthcare: past, present and future. Stroke Vasc Neurol. 2017;2(4):230–43.
Google Scholar
Sun Y, Wang X, Ren N, Liu Y, You S. Improved machine learning models by data processing for predicting life-cycle environmental impacts of chemicals. Environ Sci Technol. 2023;57(8):3434.
Google Scholar
Peiffer-Smadja N, Rawson TM, Ahmad R, Buchard A, Georgiou P, Lescure FX, et al. Machine learning for clinical decision support in infectious diseases: a narrative review of current applications. Clin Microbiol Infect. 2020;26(5):584–95.
Google Scholar
Balakrishnan V, Kherabi Y, Ramanathan G, Paul SA, Tiong CK. Machine learning approaches in diagnosing tuberculosis through biomarkers – a systematic review. Prog Biophys Mol Biol. 2023;179:16–25.
Google Scholar
Jiang F, Sun T, Cheng P, Wang J, Gong W. A summary on tuberculosis vaccine development—where to go?. J Pers Med. 2023;13(3):408.
Google Scholar
Du J, Su Y, Dong E, Qiao J, Wang R, Zhao W, et al. LTBI-negative close contacts of tuberculosis are more likely to develop the disease: enlightenment and lessons from a cluster outbreak. Front Public Health. 2023;2023(11):1136355.
Google Scholar
Ye Q, Chai X, Jiang D, Yang L, Shen C, Zhang X, et al. Identification of active molecules against Mycobacterium tuberculosis through machine learning. Brief Bioinform. 2021;22(5):bbab068.
Google Scholar
Ullah U, Tahir Z, Qazi O, Mirza S, Cheema MI. Raman spectroscopy and machine learning-based optical probe for tuberculosis diagnosis via sputum. Tuberculosis. 2022;136:102251.
Google Scholar
Wen J, Zhang Z, Lan Y, Cui Z, Cai J, Zhang W. A survey on federated learning: challenges and applications. Int J Mach Learn Cybern. 2023;14(2):513–35.
Google Scholar
Marquez ES, Hare JS, Niranjan M. Deep cascade learning. IEEE Trans Neural Netw Learn Syst. 2018;29(11):5475–85.
Google Scholar
Filikov A, Pethe S, Kelley R, Fischer A, Ozminkowski R. Use of stratified cascade learning to predict hospitalization risk with only socioeconomic factors. J Biomed Inform. 2020;104:103393.
Google Scholar
An N, Ding H, Yang J, Au R, Ang TFA. Deep ensemble learning for Alzheimer’s disease classification. J Biomed Inform. 2020;105:103411.
Google Scholar
Vamathevan J, Clark D, Czodrowski P, Dunham I, Ferran E, Lee G, et al. Applications of machine learning in drug discovery and development. Nat Rev Drug Discov. 2019;18(6):463–77.
Google Scholar
Charlton CE, Poon MTC, Brennan PM, Fleuriot JD. Development of prediction models for one-year brain tumour survival using machine learning: a comparison of accuracy and interpretability. Comput Methods Programs Biomed. 2023;233:107482.
Google Scholar
Black JE, Kueper JK, Williamson TS. An introduction to machine learning for classification and prediction. Fam Pract. 2023;40(1):200–4.
Google Scholar
Ahalya RK, Umapathy S, Krishnan PT, Joseph Raj AN. Automated evaluation of rheumatoid arthritis from hand radiographs using machine learning and deep learning techniques. Proc Inst Mech Eng H. 2022;236(8):1238–49.
Google Scholar
Silva JCF, Carvalho TFM, Basso MF, Deguchi M, Pereira WA, Sobrinho RR, et al. Geminivirus data warehouse: a database enriched with machine learning approaches. BMC Bioinformatics. 2017;18(1):240.
Google Scholar
Fleuren LM, Tonutti M, de Bruin DP, Lalisang RCA, Dam TA, Gommers D, et al. Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse. Intensive Care Med Exp. 2021;9(1):32.
Google Scholar
Fox GJ, Barry SE, Britton WJ, Marks GB. Contact investigation for tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2013;41(1):140–56.
Google Scholar
